Futura Medical (LON:FUM) Shares Down 16.4% – What’s Next?

Futura Medical plc (LON:FUM) dropped 16.4% during mid-day trading on Tuesday . The company traded as low as GBX 0.19 and last traded at GBX 0.20. Approximately 851,404 shares changed hands during trading, a decline of 92% from the average daily volume of 10,051,421 shares. The stock had previously closed at GBX 0.24.

Futura Medical Stock Performance

The firm’s fifty day simple moving average is GBX 0.36 and its 200 day simple moving average is GBX 0.71. The stock has a market capitalization of £1.28 million, a price-to-earnings ratio of -0.27 and a beta of 0.02.

Futura Medical (LON:FUM) last released its quarterly earnings results on Tuesday, September 1st. The company reported GBX (0.20) earnings per share for the quarter. Futura Medical had a negative net margin of 158.21% and a negative return on equity of 152.42%. Analysts forecast that Futura Medical plc will post 2.8486672 earnings per share for the current year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.